The complaint targets a period between January 29, 2025, and March 4, 2026, alleging that SES AI systematically overstated its growth prospects. According to the filing, the company inflated expected results from deals with firms that possessed little to no actual operations. Furthermore, the suit claims the company artificially bolstered its revenue figures through circular transactions involving Molecular Universe, while simultaneously concealing material logistics constraints that hampered fourth-quarter 2025 performance.

These omissions allegedly obscured the true state of the company's financial trajectory, leading to lower-than-expected revenue guidance for 2026. Shareholders who suffered losses during this timeframe may contact Howard G. Smith’s office at (215) 638-4847 or via email at [email protected] to discuss their legal standing. While investors do not need to take immediate action to remain part of the class, those interested in potentially serving as a lead plaintiff must meet the upcoming June 26 cutoff.